Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Shionogi & Co., a Japan-based pharmaceutical company, has planned to sell a new influenza medication in Japan by the end of 2010. The drug is in the final stage of development and the company will apply for approval from its health ministry by the end of this year. The medicine is administered by injection and requires prescription.
Subscribe to our email newsletter
Shionogi’s treatment is said to be effective even after 48 hours from the emergence of symptoms, unlike the “Tamiflu” influenza medication, which must be administered within 48 hours.
The company, which acquired the development and sales rights to the medication from a US-based firm, claims that the new medicine has proved to be effective against the highly virulent H5N1 type of influenza, or so-called bird flu.